Ontology highlight
ABSTRACT: Introduction
Glioma is the most common malignant primary brain tumor with survival outcome for patients with lower-grade gliomas (LGGs) being quite variable. Epigenetic modifications in LGGs appear tightly linked to patient clinical outcomes but are not commonly used as clinical tools.Aims
We aimed to derive an epigenetic enzyme gene signature for LGGs that would allow for improved clinical risk stratification.Results
The study employed transcriptomic data of 711 lower-grade gliomas from three publically available data sets. Based on least absolute shrinkage and selection operator (LASSO) Cox regression analysis, we discovered a 13-gene epigenetic signature that strongly predicts poor overall survival in LGGs. The robust prediction ability for survival was further v
SUBMITTER: Yu H
PROVIDER: S-EPMC7941239 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature